Package Leaflet: Information for the User
Levitra 5 mg film-coated tablets
vardenafil
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Levitra contains vardenafil, which belongs to a group of medicines called phosphodiesterase 5 inhibitors. These medicines are used to treat erectile dysfunction in adult men, a condition which is also known as impotence. This condition occurs when a man cannot achieve or maintain an erection.
At least one in ten men has, at some point, experienced problems with achieving or maintaining an erection. This can be due to either physical or psychological factors, or a combination of both. Regardless of the cause, muscle and blood vessel changes in the penis lead to insufficient blood flow to achieve and maintain an erection.
Levitra will only work when you are sexually stimulated. This medicine reduces the action of a natural chemical in your body called phosphodiesterase type 5 (PDE5), which relaxes the muscle in the blood vessels of the penis and increases blood flow.
Do not take Levitra
Warnings and precautions
Before taking Levitra, tell your doctor if you have:
Be especially cautious when taking Levitra
Children and adolescents
Levitra should not be used in children and adolescents under 18 years of age.
Other medicines and Levitra
Tell your doctor if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
Some medicines may cause problems if taken with Levitra. These include:
Do not take Levitra film-coated tablets with another medicine called Levitra orodispersible tablets.
Taking Levitra with food, drinks, and alcohol
You can take Levitra with or without food, but it is best to take it without a large or high-fat meal, as this may delay the effect.
Pregnancy and breastfeeding
Levitra is not for use in women.
Driving and using machines
Levitra may cause dizziness or affect your vision. Do not drive or operate machinery if you feel dizzy or have vision problems after taking Levitra.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is 10 mg.
Take a Levitra tablet about 25 to 60 minutes before sexual activity. With sexual stimulation, you may achieve an erection from 25 minutes up to 4-5 hours after taking Levitra.
Do not take Levitra film-coated tabletswith any other formulation of Levitra.
Do not take Levitramore than once a day.
If you feel that the effect of Levitra is too strong or too weak, talk to your doctor.
If you take more Levitra than you should
Taking too much Levitra may cause more side effects or make them worse. If you have taken more Levitra than you should, tell your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Most of the side effects are mild or moderate.
Some patients have reported a sudden decrease or loss of vision in one or both eyes. Stop taking Levitra and contact your doctor immediately.
There have also been reports of a sudden decrease or loss of hearing.
There have been reports of sudden death, fast or irregular heartbeat, heart attack, chest pain, and stroke in men taking vardenafil. Most of these men had pre-existing heart problems.
The likelihood of experiencing side effects varies from person to person. The following side effects have been reported:
Very common side effects:
may affect more than 1 in 10 people
Common side effects:
may affect up to 1 in 10 people
Uncommon side effects:
may affect up to 1 in 100 people
Rare side effects:
may affect up to 1 in 1,000 people
Very rare or unknown side effects:
may affect less than 1 in 10,000 people or the frequency cannot be estimated from the available data
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after "EXP". The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Levitra contains
In the tablet core: crospovidone, magnesium stearate, microcrystalline cellulose, anhydrous colloidal silica.
In the film coating: macrogol 400, hypromellose, titanium dioxide (E171), yellow iron oxide (E172), red iron oxide (E172).
Appearance and packaging
Levitra 5 mg film-coated tablets are orange, with the Bayer cross on one side and the strength (5) on the other. Each pack contains 2, 4, 8, 12, or 20 tablets. Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Bayer AG
51368 Leverkusen
Germany
Manufacturer
Bayer AG
Kaiser-Wilhelm-Allee
51368 Leverkusen
Germany
For further information on this medicine, contact the local representative of the marketing authorization holder.
Belgium/Belgique/Belgien | Lithuania |
Bayer SA-NV | UAB Bayer |
Tel: +32-(0)2-535 63 11 | Tel: +370 523 36 868 |
Bulgaria | Luxembourg/Luxemburg |
Bayer Bulgaria EOOD | Bayer SA-NV |
Tel: +359-(0)2-424 72 80 | Tel: +32-(0)2-535 63 11 |
Czech Republic | Hungary |
Bayer s.r.o. | Bayer Hungária KFT |
Tel: +420 266 101 111 | Tel: +36 14 87-4100 |
Denmark | Malta |
Bayer A/S | Alfred Gera and Sons Ltd. |
Tel: +45 45 23 50 00 | Tel: +35 621 44 62 05 |
Germany | Netherlands |
Jenapharm GmbH & Co. KG | Bayer B.V. |
Tel: +49 (0)3641-87 97 444 | Tel: +31-(0)297-28 06 66 |
Estonia | Norway |
Bayer OÜ | Bayer AS |
Tel: +372 655 85 65 | Tel: +47-23 13 05 00 |
Greece | Austria |
Bayer Ελλάς ΑΒΕΕ | Bayer Austria Ges. m. b. H. |
Tel: +30 210 61 87 500 | Tel: +43-(0)1-711 46-0 |
Spain | Poland |
Bayer Hispania S.L. | Bayer Sp. z o.o. |
Tel: +34-93-495 65 00 | Tel: +48 22 572 35 00 |
France | Portugal |
Bayer HealthCare | Bayer Portugal, Lda. |
Tel: +33-(0)800 87 54 54 | Tel: +351 21 416 42 00 |
Croatia | Romania |
Bayer d.o.o. | SC Bayer SRL |
Tel: +385-(0)1-6599 900 | Tel: +40-21-529 59 00 |
Ireland | Slovenia |
Bayer Limited | Bayer d.o.o. |
Tel: +353 1 216 3300 | Tel: +386 (0)1 58 14 400 |
Iceland | Slovakia |
Icepharma hf. | Bayer, spol. s r.o. |
Tel: +354-540 8000 | Tel: +421 2-59 21 31 11 |
Italy | Finland |
Bayer S.p.A. | Bayer Oy |
Tel: +39 02 397 81 | Tel: +358-20 785 21 |
Cyprus | Sweden |
NOVAGEM Limited | Bayer AB |
Tel: +357 22 48 38 58 | Tel: +46 (0)8 580 223 00 |
Latvia | United Kingdom |
SIA Bayer | Bayer plc |
Tel: +371 67 845 563 | Tel: +44 (0) 118 206 3000 |
Date of last revision of this leaflet {month, year} Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu